Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

Related Articles by Review for PubMed (Select 18589210)

1.

MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.

Taylor DD, Gercel-Taylor C.

Gynecol Oncol. 2008 Jul;110(1):13-21. doi: 10.1016/j.ygyno.2008.04.033. Erratum in: Gynecol Oncol. 2010 Jan;116(1):153.

PMID:
18589210
2.

MicroRNAs in ovarian cancer biology and therapy resistance.

van Jaarsveld MT, Helleman J, Berns EM, Wiemer EA.

Int J Biochem Cell Biol. 2010 Aug;42(8):1282-90. doi: 10.1016/j.biocel.2010.01.014. Epub 2010 Jan 18. Review.

PMID:
20083225
3.

Exosomes: proteomic insights and diagnostic potential.

Simpson RJ, Lim JW, Moritz RL, Mathivanan S.

Expert Rev Proteomics. 2009 Jun;6(3):267-83. doi: 10.1586/epr.09.17. Review.

PMID:
19489699
4.

[Molecular profiling and predictive signatures. Biomarker analysis in ovarian cancer].

Denkert C.

Pathologe. 2008 Nov;29 Suppl 2:168-71. doi: 10.1007/s00292-008-1073-4. Review. German.

PMID:
18931999
5.

Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis.

Kosaka N, Iguchi H, Ochiya T.

Cancer Sci. 2010 Oct;101(10):2087-92. doi: 10.1111/j.1349-7006.2010.01650.x. Epub 2010 Jul 7. Review.

PMID:
20624164
6.

MicroRNA signatures: novel biomarker for colorectal cancer?

Luo X, Burwinkel B, Tao S, Brenner H.

Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1272-86. doi: 10.1158/1055-9965.EPI-11-0035. Epub 2011 May 6. Review.

7.

Serum microRNAs as powerful cancer biomarkers.

Wittmann J, Jäck HM.

Biochim Biophys Acta. 2010 Dec;1806(2):200-7. doi: 10.1016/j.bbcan.2010.07.002. Epub 2010 Jul 13. Review.

PMID:
20637263
8.

Oncogenic microRNAs (OncomiRs) as a new class of cancer biomarkers.

Krutovskikh VA, Herceg Z.

Bioessays. 2010 Oct;32(10):894-904. Review.

PMID:
21105295
9.

Relevance of circulating tumor cells, extracellular nucleic acids, and exosomes in breast cancer.

Friel AM, Corcoran C, Crown J, O'Driscoll L.

Breast Cancer Res Treat. 2010 Oct;123(3):613-25. doi: 10.1007/s10549-010-0980-2. Epub 2010 Jun 15. Review.

PMID:
20549336
10.

Proteomic analysis for early detection of ovarian cancer: a realistic approach?

Stevens EV, Liotta LA, Kohn EC.

Int J Gynecol Cancer. 2003 Nov-Dec;13 Suppl 2:133-9. Review.

PMID:
14656269
11.

Biomarker discovery in epithelial ovarian cancer by genomic approaches.

Mok SC, Elias KM, Wong KK, Ho K, Bonome T, Birrer MJ.

Adv Cancer Res. 2007;96:1-22. Review.

PMID:
17161674
12.

The role of microRNAs in ovarian cancer.

Kinose Y, Sawada K, Nakamura K, Kimura T.

Biomed Res Int. 2014;2014:249393. doi: 10.1155/2014/249393. Epub 2014 Sep 10. Review.

13.

Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications.

Mezzanzanica D, Bagnoli M, De Cecco L, Valeri B, Canevari S.

Int J Biochem Cell Biol. 2010 Aug;42(8):1262-72. doi: 10.1016/j.biocel.2009.12.017. Epub 2009 Dec 24. Review.

PMID:
20035894
14.

Biomarkers of ovarian tumours.

Rapkiewicz AV, Espina V, Petricoin EF 3rd, Liotta LA.

Eur J Cancer. 2004 Nov;40(17):2604-12. Review.

PMID:
15541961
15.

microRNA and the pathogenesis of ovarian cancer--a new horizon for molecular diagnostics and treatment?

Kuhlmann JD, Rasch J, Wimberger P, Kasimir-Bauer S.

Clin Chem Lab Med. 2012 Jan 13;50(4):601-15. doi: 10.1515/cclm-2011-0847. Review.

PMID:
22505556
16.

[Screening for ovarian cancer].

Bjørge T, Dørum A, Tropé CG.

Tidsskr Nor Laegeforen. 2000 May 10;120(12):1444-8. Review. Norwegian.

PMID:
10851943
17.

Discovery and application of protein biomarkers for ovarian cancer.

Gagnon A, Ye B.

Curr Opin Obstet Gynecol. 2008 Feb;20(1):9-13. doi: 10.1097/GCO.0b013e3282f226a5. Review.

PMID:
18196999
18.

Epigenetics in ovarian cancer.

Seeber LM, van Diest PJ.

Methods Mol Biol. 2012;863:253-69. doi: 10.1007/978-1-61779-612-8_15. Review.

PMID:
22359298
19.

MicroRNAs in ovarian carcinomas.

Dahiya N, Morin PJ.

Endocr Relat Cancer. 2010 Jan 29;17(1):F77-89. doi: 10.1677/ERC-09-0203. Print 2010 Mar. Review.

20.

Early diagnosis and predictors of malignancy of adnexal masses.

Murta EF, Nomelini RS.

Curr Opin Obstet Gynecol. 2006 Feb;18(1):14-9. Review.

PMID:
16493254
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk